Can Wegovy Cause an Increased Heart Rate?

Does semaglutide actually raise your heart rate, and by how much?

The short answer is: yes, it can, and the effect is real but usually modest. In the STEP 1 trial (a 68-week study in adults with obesity published in the New England Journal of Medicine) participants taking semaglutide 2.4mg showed a small average increase in heart rate compared with placebo. The figure observed across the trial programme is typically cited as around 1–5 beats per minute above baseline, though individual variation is wide.

GLP-1 receptor agonists like semaglutide act on receptors present in the heart as well as the gut. The mechanism behind the heart-rate rise is not fully understood, but it is thought to involve direct GLP-1 receptor activity on cardiac tissue rather than being secondary to weight loss itself. This matters because the increase can appear early, before significant weight has been lost.

The NHS medicines page for semaglutide lists a fast or irregular heartbeat among the side effects that warrant a call to a GP or prescriber. For most people the elevation is clinically inconsequential; for a small number it is more pronounced or uncomfortable, and if you want a closer look at what the evidence says, our page on whether Wegovy can cause an increased heart rate covers the topic in detail. Understanding which group you fall into is part of the ongoing clinical conversation, not something to guess at.

Is a raised heart rate more likely at certain doses or times?

Timing matters here. The increase in heart rate tends to be most noticeable in the weeks after starting treatment or following a dose step up. As your body adjusts to a given dose level, the effect often plateaus or eases. This is consistent with the broader pattern of Wegovy side effects: most are sharpest during change, then settle.

The dose schedule for Wegovy progresses slowly (roughly every four weeks) specifically to give the body time to adapt. Rushing through a titration or returning from a break in treatment at the same dose (rather than stepping back) can make side effects, including heart-rate changes, feel more pronounced. If you have restarted treatment after a gap, your prescriber may advise going back to a lower dose temporarily; this is a clinical decision, not one to make independently.

One practical note: if you time your injection around a busy or stressful period (Monday mornings, returning from a holiday) it can be harder to distinguish a drug-related heart rate change from ordinary stress or physical activity. Checking your resting pulse first thing in the morning, before getting up, gives a more representative baseline, and our page on whether Wegovy increases resting heart rate explains what to look for and how to interpret those readings.

When should an increased heart rate on Wegovy prompt medical advice?

A small, asymptomatic rise in resting pulse is not generally a reason to stop treatment. A larger rise, palpitations that feel fluttery or irregular, dizziness, shortness of breath, or any chest discomfort are different. These warrant prompt contact with a prescriber or GP, same day if the symptoms are new or severe.

People with pre-existing arrhythmias or other cardiac conditions should ensure their prescriber is aware before starting semaglutide. The medicine does carry a broad body of cardiovascular outcome data: the SELECT trial demonstrated reduced risk of major cardiovascular events in adults with established heart disease and obesity, which is why the cardiovascular benefits of semaglutide are a significant part of its clinical profile. A modestly elevated heart rate must be weighed against this broader picture by a clinician who knows your history.

You can also report any suspected side effect directly through the MHRA's Yellow Card scheme, patients can submit reports themselves, and it contributes to ongoing safety monitoring of the medicine.

Does this affect whether Wegovy is right for you?

A tendency toward a higher resting heart rate does not automatically rule out Wegovy, but it is the kind of detail a prescriber needs to know about before treatment starts. Factors such as existing cardiac conditions, other medicines that affect heart rhythm, and your baseline pulse all feed into the clinical assessment.

If you are considering Wegovy and want to understand your options, the free consultation at nume is the place to start. A GPhC-registered prescriber reviews your health picture personally (not software) and can discuss whether semaglutide is clinically suitable for you. You can also read a broader overview on the weight-loss treatment options page if you want to compare the choices before booking.

For those already on treatment who have a concern, the aftercare team is available seven days a week. Concerns about heart rate mid-treatment are exactly the kind of thing that should go to your prescriber rather than an internet search.